Loading…
Lobbying Spend
—
Filings
41
Firms Hired
2
Active Period
2013–2022
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Preserving Patient Access to Compounded Medications Act of 2019
2020 · fourth_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · fourth_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · fourth_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · fourth_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · fourth_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · fourth_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · third_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · third_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · third_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · second_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · second_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · second_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · second_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · second_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · second_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · first_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · first_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2020 · first_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2019 · fourth_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2019 · fourth_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2019 · fourth_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2019 · third_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2019 · third_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2019 · third_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Preserving Patient Access to Compounded Medications Act of 2019
2019 · second_quarter · Firm: ROCK & ASSOCIATES
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications.
Client expense: — · Firm income: $11,250
Matched citations: H.R.1959
Source: Senate LDA